Zhao 2021 Mol Biomed: Difference between revisions
(Created page with "{{Publication |title=Zhao H, Li Y (2021) Cancer metabolism and intervention therapy. Mol Biomed 2:5. https://doi.org/10.1186/s43556-020-00012-1 |info=[https://pubmed.ncbi.nlm....") Β |
No edit summary |
||
Line 8: | Line 8: | ||
|editor=Gnaiger E | |editor=Gnaiger E | ||
}} | }} | ||
[[File:Zhao 2021 Mol Biomed CORRECTION.png|right|300px]] | |||
{{Template:Correction FADH2 and S-pathway}} | |||
{{Labeling | {{Labeling | ||
|diseases=Cancer | |diseases=Cancer | ||
|enzymes=Complex II;succinate dehydrogenase | |enzymes=Complex II;succinate dehydrogenase | ||
}} | }} | ||
Revision as of 10:28, 16 September 2023
Zhao H, Li Y (2021) Cancer metabolism and intervention therapy. Mol Biomed 2:5. https://doi.org/10.1186/s43556-020-00012-1 |
Zhao H, Li Y (2021) Mol Biomed
Abstract: Metabolic reprogramming with heterogeneity is a hallmark of cancer and is at the basis of malignant behaviors. It supports the proliferation and metastasis of tumor cells according to the low nutrition and hypoxic microenvironment. Tumor cells frantically grab energy sources (such as glucose, fatty acids, and glutamine) from different pathways to produce a variety of biomass to meet their material needs via enhanced synthetic pathways, including aerobic glycolysis, glutaminolysis, fatty acid synthesis (FAS), and pentose phosphate pathway (PPP). To survive from stress conditions (e.g., metastasis, irradiation, or chemotherapy), tumor cells have to reprogram their metabolism from biomass production towards the generation of abundant adenosine triphosphate (ATP) and antioxidants. In addition, cancer cells remodel the microenvironment through metabolites, promoting an immunosuppressive microenvironment. Herein, we discuss how the metabolism is reprogrammed in cancer cells and how the tumor microenvironment is educated via the metabolic products. We also highlight potential metabolic targets for cancer therapies.
β’ Bioblast editor: Gnaiger E
Correction: FADH2 and Complex II
- FADH2 is shown as the substrate feeding electrons into Complex II (CII). This is wrong and requires correction - for details see Gnaiger (2024).
- Gnaiger E (2024) Complex II ambiguities β FADH2 in the electron transfer system. J Biol Chem 300:105470. https://doi.org/10.1016/j.jbc.2023.105470 - Β»Bioblast linkΒ«
Labels: Pathology: Cancer
Enzyme: Complex II;succinate dehydrogenase